| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hyperion Defi, Inc. (HYPD) has 7 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. HYPD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.39M | $5.14M | +8.0K | |
| CFO | 327.9K | $1.22M | - | |
| Dir | 111.9K | $415.3K | - | |
| Dir | 88.0K | $326.5K | - | |
| Other | 75.0K | $278.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 28, 2018 | Ianchulev Tsontcho77 | Chief Executive Officer | Buy | 6,000 | $6.63 | $39,780.00 | New | |
| Jan 29, 2018 | Senju Pharmaceutical Co., Ltd. | 10% Owner | Buy | 100,000 | $10.00 | $1,000,000.00 | +6.2% | |
| Jan 29, 2018 | Yoshida Shuhei | Director, 10% Owner | Buy | 100,000 | $10.00 | $1,000,000.00 | +6.2% | |
| Jan 29, 2018 | Mario Ernest | Director | Buy | 90,000 | $10.00 | $900,000.00 | +61.3% | |
| Jan 29, 2018 | Ianchulev Tsontcho77 | Chief Executive Officer | Buy | 10,000 | $10.00 | $100,000.00 | +114.3% | |
| Jan 29, 2018 | Eshelman Fredric N | Director, 10% Owner | Buy | 335,000 | $10.00 | $3,350,000.00 | +35.7% | |
| Jan 29, 2018 | Labelle Curt H | Director, 10% Owner | Buy | 10,000 | $10.00 | $100,000.00 | New |